Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M. El Sahly, Jacqueline M. Miller, Judith M. Martin et al.|New England Journal of Medicine|2021Cited by 661
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phasesLindsey R. Baden, Jacqueline M. Miller, Hana M. El Sahly et al.|Nature Communications|2024Cited by 35